ADVISORY/UCSF ARI Media Briefing On Monday, June 26 Will Preview World AIDS Conference in South Africa.

News/Assignment Editors and Science/Medical Writers

ADVISORY... for Monday (June 26)

--(BW HealthWire)

A UCSF AIDS Research Institute (ARI) news briefing for local media in advance of the XIII International AIDS Conference will take place next Monday, June 26.

More than 50 UCSF ARI scientists are expected to present at the international meeting, July 9 to 14 in Durban, South Africa.

The UCSF ARI briefing will include overviews of key issues expected in Durban by leading UCSF researchers and short summaries by UCSF scientists about their presentations. An additional conference room has been reserved for individual interviews with scientists during and after the briefing. Television crews are welcome to set-up in this room for interviews.

   UCSF research being reported at the International AIDS Conference
          is embargoed until time of presentation in Durban.

THE BRIEFING IS SET FOR:

      DATE:: Monday, June 26

      TIME: 1:00 to 4:30 PM

      LOCATION: UCSF AIDS Research Institute
              Suite 200
              74 New Montgomery Street
              San Francisco

UCSF MEDIA BRIEFING: XIII INTERNATIONAL AIDS CONFERENCE

12:30 to 1:00 p.m.

    Early Arrival -- Sandwiches, refreshments and media packets will
    be available

1:00 to 1:10

    "Introduction"

      --  Thomas J. Coates, PhD, executive director, UCSF AIDS Research
        Institute.

1:10 to 1:20

    Overview of UCSF ARI International Research Program

      --  Nancy Padian, MPH, PhD, director of the UCSF ARI International
        Research Program and UCSF professor of obstetrics, gynecology,
        and reproductive sciences and epidemiology.

                         CLINICAL SCIENCE (1)

1:20 to 1:35

    "A Randomized Trial of IL-2 Added to HAART for Primary HIV"

      --  Frederick Hecht, MD, assistant clinical professor of medicine
        in the UCSF Positive Health Program at San Francisco General
        Hospital Medical Center.

1:35 to 1:50

    "Immunologic Improvement Associated with HIV-1 Suppression Among
    Persons Receiving Subcutaneous IL-2 Treatment: A Randomized
    Clinical Trial"

      --  James O. Kahn, MD, associate professor of medicine in the UCSF
        Positive Health Program at San Francisco General Hospital
        Medical Center.

1:50 to 2:00

    "Trends in AIDS Survival in San Francisco: Does Treatment Continue
    to be Effective?"

      --  Sandra Schwarcz, MD, MPH, UCSF Center for AIDS Prevention
        Studies and San Francisco Department of Public Health.

                              PREVENTION

2:00 to 2:20

    Overview: Prevention

    "Voluntary Counseling and Testing Efficacy Study: A Randomized
    Trial in Three Developing Countries"

    "Cost-Effectiveness of Voluntary HIV-1 Counseling and Testing in
    Reducing SexualTransmission of HIV-1 in Nairobi, Kenya and Dar es
    Salaam, Tanzania: the Voluntary HIV-1 Counseling and Testing
    Efficacy Study"

      --  Thomas J. Coates, PhD, executive director, UCSF AIDS Research
        Institute.

                             EPIDEMIOLOGY

2:20 to 2:30

    Overview: Epidemiology

      --  Susan Buchbinder, MD, UCSF assistant clinical professor of
        medicine and San Francisco Department of Public Health.

2:30 to 2:40

    "Incidence and Prevalence of HIV and STD among Incarcerated
    Persons upon Intake: Implications for Prevention and Treatment"

      --  Willi McFarland, MD, PhD, UCSF Center for AIDS Prevention
        Studies and San Francisco Department of Public Health.

2:40 to 2:50

    "Increased Incidence of HIV and Evidence of Transmission of
    Resistant Virus Among Anonymous Test Site Attendees in Santos,
    Brazil, 1995-1999"

      --  Kimberly Page-Shafer, PhD, MPH, UCSF Center for AIDS
        Prevention Studies.

                                POLICY

2:50 to 3:00

    Overview: Policy

      --  Steve Morin, PhD, director of the Policy Center, UCSF AIDS
        Research Institute.

3:00 to 3:20

    "Cost-effectiveness of the Female Condom in Preventing HIV and
    STDs in Commercial Sex Workers in Rural South Africa"

    "The Costs and Benefits of Employer-sponsored Antiretroviral Drug
    Provision in a Ugandan Corporation"

      --  Elliot Marseille, DrPH, MPP, UCSF and Health Strategies
        International.

                         CLINICAL SCIENCE (2)

3:20 to 3:30

    "Short-Term Effects of Cannabinoids on HIV-1 Viral Load"

      --  Donald Abrams, MD, professor of medicine in the UCSF Positive
        Health Program at San Francisco General Hospital Medical
        Center.

3:30 to 3:40

    Overview: Clinical Science

      --  Paul Volberding, MD, director, UCSF Positive Health Program at
        San Francisco General Hospital Medical Center.